Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults
Clinical trial NCT03392389 · COMPLETED
Trial details
- NCT number
- NCT03392389
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-04
- Primary completion
- 2019-07-29
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.